Stammdaten
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.
Unternehmen & Branche
| Name | SBC Medical Group Holdings Inc |
|---|---|
| Ticker | SBC |
| CIK | 0001930313 |
| Boerse | US |
| Sektor | Industrials |
| Industrie | Consulting Services |
| SIC | 8011 · Services-Offices & Clinics of Doctors of Medicine |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 344,1 Mio. USD |
| Beta | 0,99 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 173,607,489 | 50,985,613 | 0.50 | 380,447,946 | 248,282,196 |
| 2025-09-30 | 10-Q | 43,353,235 | 12,824,636 | 0.12 | 321,363,085 | 247,988,292 |
| 2025-06-30 | 10-Q | 43,358,847 | 2,458,240 | 0.02 | 315,299,257 | 244,591,991 |
| 2025-03-31 | 10-Q | 47,328,701 | 21,502,446 | 0.21 | 284,605,789 | 226,446,266 |
| 2024-12-31 | 10-K | 205,415,542 | 46,614,275 | 0.48 | 266,083,154 | 195,109,157 |
| 2024-09-30 | 10-Q | 53,084,883 | 2,832,894 | 0.03 | 296,478,592 | 204,981,054 |
| 2024-06-30 | 10-Q | 53,102,080 | 18,484,408 | 0.20 | 19,525,808 | 8,830,564 |
| 2024-03-31 | 10-Q | 54,808,042 | 18,757,752 | 0.20 | 19,750,055 | 9,017,773 |
| 2023-12-31 | 10-K | 193,542,423 | 39,370,036 | 0.42 | 258,805,271 | 142,159,177 |
| 2023-09-30 | 10-Q | 47,278,685 | 8,356,414 | 0.09 | 21,448,334 | -5,569,632 |
| 2023-06-30 | 10-Q | 196,786 | 21,591,924 | -5,206,257 | ||
| 2023-03-31 | 10-Q | 613,333 | 120,826,577 | -3,733,159 | ||
| 2022-12-31 | 10-K | 552,813 | 119,942,205 | -3,358,671 | ||
| 2022-09-30 | 10-Q | -11,419 | 119,070,801 | -3,156,105 | ||
| 2022-06-30 | 10-Q | -1,281 | 362,107 | 23,380 | ||
| 2022-03-31 | 10-Q | -339 | 24,661 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | Aikawa Yoshiyuki | Director, Officer, 10% Owner, Chairman and CEO | Open Market Sale | -465,000 | 3.02 | -1,405,462.50 | -20,9% | |
| 2026-04-21 | Aikawa Yoshiyuki | Director, Officer, 10% Owner, Chairman and CEO | Open Market Sale | -3,100,000 | 3.02 | -9,369,750.00 | -139,5% | |
| 2026-03-06 | Aikawa Yoshiyuki | Director, Officer, 10% Owner, Chairman and CEO | Open Market Sale | -4,422,900 | 2.12 | -9,376,548.00 | -139,6% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.